In the News

05/21/2018

NaviGate Cardiac Structures Inc. (“NCSI”) reports “excellent valvular function” at 1-year follow-up of first patient to receive GATE™ tricuspid valved stent via transjugular access

NaviGate Cardiac Structures Inc. (“NCSI”) announced today that the first patient to receive its replacement tricuspid valved stent via transjugular access has reached one-year post-procedure with excellent valvular function.


05/21/2018

NaviGate Cardiac Structures Inc. (“NCSI”) reports “excellent valvular function” at 1-year follow-up of first patient to receive GATE™ tricuspid valved stent via transjugular access

NaviGate Cardiac Structures Inc. (“NCSI”) announced today that the first patient to receive its replacement tricuspid valved stent via transjugular access has reached one-year post-procedure with excellent valvular function. This patient, along with 15 others treated to date under compassionate use protocols for severe tricuspid regurgitation, have received NCSI’s GATE™ tricuspid valved stent designed to lead to restored valvular function and improved quality of life.


05/19/2018

Assay May Help Avoid Needless Prostate Biopsies

An assay that identifies abnormal PSA proteins showed promise as an aid to avoid unnecessary prostate biopsies triggered by worrisome PSA test results, according to data reported here.


05/02/2018

Cleveland Clinic innovation team shares strategic formula for tech transformation

Wouldn’t you like a look inside the Cleveland Clinic’s innovation mindset? Attendees at the HIMSS and Health 2.0 Dev4Health event here this week got just such a glimpse.


05/01/2018

ClearFlow Reports: ERAS Cardiac Surgery Recommends Active Tube Clearance Methodology in Consensus Statement Presented at the 98th Annual Meeting of The American Association for Thoracic Surgeons

ClearFlow Inc. has announced that an international society of leading heart surgeons known as ERAS® Cardiac Surgery presented evidenced-based expert consensus statements at the 98th annual meeting of the American Association for Thoracic Surgeons on April 28, 2018. Amongst key recommendations to promote enhanced patient outcomes after cardiac surgery is the use of Active Clearance techniques to maintain chest tube patency. The PleuraFlow® ACT® System is the only FDA cleared device with the indication to prevent or minimize retained blood in patients recovering from heart surgery.


05/01/2018

Dev4Health conference examines how data sharing improves health care for patients, doctors

The health care industry is converging on ways for designers to create software that helps patients stay healthy and doctors deliver better and cheaper health care. It's a concept that's taking place at the Dev4Health conference downtown.


05/01/2018

ClearFlow Reports: ERAS Cardiac Surgery Recommends Active Tube Clearance Methodology in Consensus Statement Presented at the 98th Annual Meeting of The American Association for Thoracic Surgeons

ClearFlow Inc. has announced that an international society of leading heart surgeons known as ERAS® Cardiac Surgery presented evidenced-based expert consensus statements at the 98th annual meeting of the American Association for Thoracic Surgeons on April 28, 2018.


04/26/2018

And let there be innovation!

Innovation in healthcare will bring with it innovation in the way healthcare is consumed and delivered. The emphasis on innovation will drive more efficient technology-enabled care models, integrated delivery designs which are tailor made to meet the specific needs of the patient.


04/24/2018

2nd Annual Medical Capital Innovation Competition Winners Announced

BioEnterprise, in partnership with the Global Center for Health Innovation (Global Center), Cuyahoga County, and Healthcare Information and Management Systems Society (HIMSS) is pleased to announce the winners of the second annual Medical Capital Innovation Competition, “The Next Generation of Healthcare”:


04/17/2018

28 Teams Chosen for 2nd Annual Medical Capital Innovation Competition

BioEnterprise, in partnership with the Global Center for Health Innovation (Global Center), Cuyahoga County, and Healthcare Information and Management Systems Society (HIMSS) is pleased to announce the participants of the second annual Medical Capital Innovation Competition (MCIC2) to be held at the Global Center for Health Innovation in Cleveland, April 23-24, 2018.


   <  8 - 9 - 10 - 11 - 12 - 13 - 14 - 15 - 16 - 17  >   

Get In Touch With Us